「B Cell」の共起表現一覧(1語右で並び替え)
該当件数 : 42件
| TNFRSF17 has been shown to interact with the | B-cell activating factor TNFSF13B. |
| TNFRSF13B has been shown to interact with | B-cell activating factor, TRAF6, TRAF5, TNFSF13, TRAF |
| igand CD70, and plays a key role in regulating | B-cell activation and immunoglobulin synthesis. |
| This gene encodes the Ig-alpha protein of the | B-cell antigen component. |
| This gene encodes the Ig-beta protein of the | B-cell antigen component. |
| e necessary for expression and function of the | B-cell antigen receptor. |
| The gene is expressed in | B-cell but not T-cell or myeloid cell lines. |
| ion of B-cells during cytogenetic diagnosis of | B-cell cancers such as chronic lymphocytic leukemia. |
| B-cell chronic lymphocytic leukemia (B-CLL) - Phase I | |
| mias, acute nonlymphocytic leukemias, and some | B-cell chronic lymphocytic leukemias. |
| nt for B-lineage maturation and antigen-driven | B-cell differentiation, and it may regulate the migra |
| B-cell growth factor is released by T lymphocytes aft | |
| B-cell growth factor 1, 12kDa, also known as BCGF1, i | |
| erexpression of Baff in mice results in mature | B-cell hyperplasia and symptoms of systemic lupus ery |
| When a | B-cell is activated by its first encounter with an an |
| CD79A has been shown to interact with | B-cell linker and Alpha-1-microglobulin/bikunin precu |
| ygenase, Lymphocyte cytosolic protein 2, GAB2, | B-cell linker, Abl gene, CD28, FRS2, Mitogen-activate |
| B-cell lymphoma 6 protein is a protein that in humans | |
| Bcl-2 ( | B-cell lymphoma 2) is the founding member of the Bcl- |
| Bcl-2 derives its name from | B-cell lymphoma 2, as it is the second member of a ra |
| oclonal antibody designed for the treatment of | B-cell lymphoma. |
| B-cell lymphoma/leukemia 11B is a protein that in hum | |
| B-cell lymphoma/leukemia 10 is a protein that in huma | |
| B-cell lymphoma/leukemia 11A is a protein that in hum | |
| hogenesis since translocations associated with | B-cell malignancies also deregulates its expression. |
| splantation, and corneal transplantation), and | B-cell malignancies such as CLL/small lymphocytic lym |
| ene whose translocation may be associated with | B-cell malignancies. |
| nd gliadin peptides to T-cells which stimulate | B-cell maturation and proliferation to plasma cells m |
| se (PNP) inhibitor for the treatment of T- and | B-cell mediated disorders. |
| CD25 is expressed in most | B-cell neoplasms, some acute nonlymphocytic leukemias |
| fractory low-grade, follicular, or transformed | B-cell NHL, where no prior anti-CD20 therapy was allo |
| o market Treanda for the treatment of indolent | B-cell non-Hodgkin's lymphoma (NHL) that has progress |
| olidation therapy for patients with follicular | B-cell non-Hodgkin's lymphoma who achieved a response |
| vely, Syk and Zap-70 transmit signals from the | B-Cell receptor and T-Cell receptor. |
| The | B-cell receptor is a transmembrane receptor protein l |
| It is involved in | B-cell receptor induced Ca2+ mobilization from intrac |
| B-1 cells have limited diversity of their | B-cell receptor due to their lack of the enzyme termi |
| membrane protein that forms a complex with the | B-cell receptor (BCR) and generates a signal followin |
| BANK1 ( | B-cell scaffold protein with ankyrin repeats) is a ge |
| has a specific use in cancer diagnostics as a | B-cell specific mitogen in cytogenetic testing. |
| B cell-activating factor (BAFF) enhances | B-cell survival in vitro and is a regulator of the pe |
| pal receptor required for BAFF-mediated mature | B-cell survival. |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると
|
検索履歴を保存できる！
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|
